Is the promise of faster access to transformative medicine a good deal for patients or an inducement to keep drug companies in the UK? Nigel Hawkes reports The government has promised NHS patients faster access to new drugs or technologies at no additional cost and without compromising safety.1 The Accelerated Access Review follows almost 20 reports and reviews of innovation in the NHS over the past decade. Its aims have been generally welcomed despite doubts that all or any of them can be achieved, never mind all three at once. Barbara Harpham, chair of the Medical Technology Group, which works to improve access to technology, said she sincerely hoped that the measures would deliver. But she said that mandatory funding had not been promised for all guidance from the National Institute for Health and Care Excellence (NICE), adding that the aim of fast tracking just five new drugs or devices a year was not ambitious enough. Roy …

中文翻译：

---

政府启动计划，每年提供五项“突破性技术”

对于患者而言，更快获得转化医学的承诺对患者来说是一笔好买卖，还是诱使他们将药物公司留在英国？奈杰尔·霍克斯（Nigel Hawkes）报告政府已承诺，国民保健服务（NHS）患者在不增加安全性的前提下，无需增加任何额外费用就可以更快地获得新药或新技术。1在过去十年中，《加速获取评论》（Accelerated Access Review）追踪了近20篇有关国民保健服务（NHS）创新的报告和评论。尽管人们怀疑它的全部或任何一个目标可以实现，但它的目标还是受到了普遍欢迎，不要介意同时实现这三个目标。致力于改善技术获取的医疗技术小组主席Barbara Harpham表示，她衷心希望这些措施能够兑现。但是她说，国家健康与护理卓越研究所（NICE）并未为所有指南提供强制性资金，补充说，每年仅跟踪五种新药或新设备的目标还不够雄心勃勃。罗伊...